We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

15 hedge funds and large institutions have $974K invested in Pear Therapeutics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
+$22K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$233K
2
SCM
Saba Capital Management
New York
+$206K
3
UOC
UBS O'Connor
Illinois
+$81.2K
4
OCM
Oribel Capital Management
New York
+$68.9K
5
SC
Sculptor Capital
New York
+$65K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$226K +$233K +238,631 New
SCM
2
Saba Capital Management
New York
$201K +$206K +211,664 New
BFM
3
Boothbay Fund Management
New York
$150K +$15.1K +15,500 New
UOC
4
UBS O'Connor
Illinois
$69K +$81.2K +83,330 New
OCM
5
Oribel Capital Management
New York
$67K +$68.9K +70,701 New
Verition Fund Management
6
Verition Fund Management
Connecticut
$57K +$58.9K +60,416 New
SC
7
Sculptor Capital
New York
$55K +$65K +66,666 New
PAMP
8
Polar Asset Management Partners
Ontario, Canada
$48K +$48.8K +50,000 New
FTCM
9
Fir Tree Capital Management
New York
$32K +$32.5K +33,329 New
CH
10
CVI Holdings
Delaware
$16K +$16.2K +16,666 New
WA
11
Whitebox Advisors
Minnesota
$16K +$16.3K +16,766 New
Goldman Sachs
12
Goldman Sachs
New York
$13K +$12.9K +13,180 New
ACM
13
Atalaya Capital Management
New York
$8K +$8.13K +8,333 New
DCM
14
DG Capital Management
New York
$8K +$8.13K +8,333 New
VI
15
Vestcor Inc
New Brunswick, Canada
$8K +$8.13K +8,333 New

PEARW Hedge Fund Activity: Q1 2021 in Review

15 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q1 2021, worth a combined $974K.

Buyers outnumbered sellers: 15 funds opened new PEARW positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $233K.

  • 15 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $974K of Pear Therapeutics, Inc. Warrant stock for Q1 2021.
  • 15 funds opened new Pear Therapeutics, Inc. Warrant positions in Q1 2021 and 0 closed out, a net change of +15 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q1 2021 was Citadel Advisors, an estimated $233K added.

Based on aggregated 13F filings for Q1 2021.